Since 1997, the University of Pittsburgh, led mainly by School of Medicine faculty, has ranked among the top 10 recipients of National Institutes of Health (NIH) funding.
Within the School of Medicine, areas of research emphasis and strength include drug discovery and design; vaccine development; comparative effectiveness research; organ transplantation/immunology; stem cell biology and tissue engineering; medical device development; vascular biology; cancer research and therapy; cardiology and cardiovascular biology; bioinformatics and computational biology; psychiatry, neurobiology, systems neuroscience, and neurological surgery; structural biology; developmental biology; and clinical research/clinical trials.
The School of Medicine is continuing to expand its research facilities. A pivotal recent addition is the 10-story, 335,000-square-foot Biomedical Science Tower 3, which houses the Center for Vaccine Research; the Drug Discovery Institute; the structural biology and computational biology programs, which are among the most advanced in the country; the Pittsburgh Institute for Neurodegenerative Diseases; and 10,000 tanks for zebrafish, one of the most popular model systems for developmental research. In addition, 161,000 square feet of research space in the new Bridgeside Point II building near campus is expected to be fully occupied this year; the 218,000-square-foot John G. Rangos Sr. Research Center at Childrens Hospital of Pittsburgh of UPMC opened in late 2008; and Magee-Womens Research Institute doubled its research space with a new facility in 2007.
University projects in the planning or implementation stages include a biomedical research facility near UPMC Shadyside; the renovation of 44,000 square feet in the Thomas E. Starzl Biomedical Science Tower to accommodate the Vascular Medicine Institute and the Division of Pulmonary, Allergy, and Critical Care Medicine; a biomedical research and biotechnology center near Palermo, Italy, which is being funded, in part, by the Italian government and jointly overseen by the School of Medicine and UPMC; and additions to Salk Hall and to the Graduate School of Public Health. The University of Pittsburgh has a Clinical and Translational Science Institute and is at the forefront of moving science to practice. The Pittsburgh Life Sciences Greenhouse is a collaborative effort to support start-up biosciences companies in medical devices, therapeutics, diagnostics/screening, biotechnology, and health information technology.
The RAND Corporation founded a Pittsburgh branch, through which it developed the RAND-University of Pittsburgh Health Institute, a collaborative venture between RAND Health, Pitt's schools of the health sciences and Magee-Womens Research Institute. The emphasis is on shared activities in research, education, and training, with particular focal areas being research in women's health, mental health, patient safety, health disparities, and translation of research into evidence-based health care.
Click Here to discover more information about the School of Medicine's Research opportunities.
Faculty Research Interest Project (FRIP)
FRIP is a searchable index of terms describing the current research interests of health sciences faculty at the University of Pittsburgh. Participants include faculty from the University's six health sciences schools (Medicine, Pharmacy, Public Health, Health and Rehabilitation Sciences, Nursing, and Dental Medicine) and its Health Sciences Library System.
Over 1,800 faculty have submitted information about their interests. The index can be searched by research interest term, faculty name, and school.